Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-476-5 | CAS number: 2778-96-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Effects on fertility
Description of key information
Reproductive Toxicity:
Based on the data available from different studies, the No Observed Adverse Effect Level (NOAEL) was considered to be 1000 mg/kg/day for reproductive toxicity, when rodents were treated with test material orally by gavage. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Experimental data of read across substances
- Justification for type of information:
- Weight of evidence approach based on the data of the read-across chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: As mention below
- Principles of method if other than guideline:
- WoE report is based on reproductive toxicity studies i.e. WoE-2,WoE-3 and WoE-4.
- GLP compliance:
- not specified
- Limit test:
- no
- Justification for study design:
- No data available
- Species:
- rat
- Strain:
- other: 2.Sprague-Dawley 3.Crj: CD(SD) 4.Sprague-Dawley
- Details on species / strain selection:
- No data available
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 2.Details on test animal
TEST ANIMALS
- Source: Central Animal Facility (CAF), NIPER, Sector-67, S.A.S. Nagar, 160 062, Punjab, India.
- Age at study initiation: 7 to 8 weeks old
- Weight at study initiation: Male: 205.78-247.70 g, Female : 185.58-235.40 g
- Fasting period before study: No data available
- Housing: Animals were housed in sterilized solid bottom polypropylene cages with stainless steel grill tops with facilities for food, water bottles and bedding of clean paddy husk. The cages were suspended on stainless steel racks. Animals were identified by assigning a unique identification (ID) number written on the tail, also specified on individual cage tag.
- Diet (e.g. ad libitum): Standard laboratory sterile extruded pelleted rodent feed (Batch No. 0001642169) manufactured by Provimi Animal Nutrition India Pvt. Ltd., Bangalore, ad libitum.
- Water (e.g. ad libitum): Potable tap water filtered through Reviva Reverse Osmosis System (water filter cum purifier) of Eureka Forbes in polypropylene bottles with stainless steel sipper tubes. ad libitum.
- Acclimation period: Five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%):30-70 %,
- Air changes (per hr): 25 ± 5 air changes per hour.
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark
3.Details on test animals and env. conditions
TEST ANIMALS
- Source: Charles River Japan
- Age at study initiation: 8 weeks old
- Weight at study initiation: male 312.1 to 363.7 g, female 205.3 -230.8 g).
- Fasting period before study:
- Housing: individually housed in a wire mesh floor cage (Nihon Cage ), raised, and allowed to take solid feed
(CE - 2, Japan Clea )
- Use of restrainers for preventing ingestion (if dermal): yes/no
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period:7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24 ± 1 ° C.
- Humidity (%):50 to 65%,
- Air changes (per hr): about 15 times / hour
- Photoperiod (hrs dark / hrs light): a lighting condition set at 12 hours of lighting (7 am to 7 pm) - Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- corn oil
- Details on exposure:
- 2.Details on oral exposure
PREPARATION OF DOSING SOLUTIONS: Dose was freshly prepared prior to dosing on each day. Corn oil was used as a vehicle for this study.Test chemical was administered to each rat at the dose levels of 250, 500 and 1000 mg/kg in the dose volume of 5 ml/kg body weight. The chemical was weighed on a weighing balance. Then, it was transferred to calibrated falcon tube. Some quantity of the corn oil was added initially and vortexed. The sufficient quantity of vehicle was added to make up the required volume of dose.
DIET PREPARATION
- Rate of preparation of diet (frequency): No data available
- Mixing appropriate amounts with (Type of food): No data available
- Storage temperature of food: No data available
VEHICLE
- Justification for use and choice of vehicle (if other than water): Chemical was insoluble in water, the corn oil was used as vehicle to deliver the desired dose levels as it is also recommended in the toxicological evaluation guidelines.
- Concentration in vehicle: 0, 250, 500 and 1000 mg/kg/day
- Amount of vehicle (if gavage): 5 ml of corn oil
- Lot/batch no. (if required): Batch no. 51
- Purity: No data available
3.Details on exposure
PREPARATION OF DOSING SOLUTIONS:
The test substance was prepared by suspending it in corn oil and used as a test sample
DIET PREPARATION
- Rate of preparation of diet (frequency):No data available
- Mixing appropriate amounts with (Type of food )
- Storage temperature of food: No data available
VEHICLE
- Justification for use and choice of vehicle (if other than water): corn oil
- Concentration in vehicle: 0 ,100, 300 and 1,000 mg/kg bw/day
- Amount of vehicle (if gavage): 5ml/kg bw
- Lot/batch no. (if required): (Lot No. V 6 H 2050, Nacalai Tesque ),
- Purity: No data available
4.Details on exposure
PREPARATION OF DOSING SOLUTIONS:
Test material dissolved in corn oil.
DIET PREPARATION
- Rate of preparation of diet (frequency):No data available
- Mixing appropriate amounts with (Type of food )
- Storage temperature of food: No data available
VEHICLE
- Justification for use and choice of vehicle (if other than water): corn oil
- Concentration in vehicle: 0 ,250, 500 and 1,000 mg/kg bw/day
- Amount of vehicle (if gavage): No data available
- Lot/batch no. (if required): No data available
- Purity: No data available - Details on mating procedure:
- 3.- M/F ratio per cage: 1/1
- Length of cohabitation: at the most 14days
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancy : until proof of pregnancy (formation of vaginal closing or sperm detection in vagina) - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- 2.The tet chemical (250, 500 and 1000 mg) was weighed on balance and dissolved in 5 ml of corn oil. An aliquot (5µl) was taken from three different layers of the dose preparations and was mixed in toluene to make the final volume 1ml. The concentration of the substence in each layer was calculated using the calibration curve of standard (5 mg / ml toluene) by UV - Visible spectroscopy using Flex Station at 600 nm.
- Duration of treatment / exposure:
- 2.28 days.
Study1;
Male rats :from two weeks prior to mating, during the mating period and, approximately, two weeks post mating (at least 28 days),
female rats :from two weeks prior to mating, during the mating period, gestation period and 3 days after lactation
3.Males: 42 days
Females: from 14 days prior to mating to day 3 of lactation
4.Male rats :from two weeks prior to mating, during the mating period and, approximately, two weeks post mating (at least 28 days),
female rats :from two weeks prior to mating, during the mating period, gestation period and 3 days after lactation - Frequency of treatment:
- daily
- Details on study schedule:
- No data available
- Remarks:
- 2. 0 ,250, 500 and 1,000 mg/kg bw/day
- Remarks:
- 3. 0 ,100, 300 and 1,000 mg/kg bw/day
- Remarks:
- 4. 0 ,250, 500 and 1,000 mg/kg bw/day
- No. of animals per sex per dose:
- 2.Total: 56
0 mg/kg/day: 7 male, 7 female
250 mg/kg/day: 7 male, 7 female
500 mg/kg/day: 7 male, 7 female
1000 mg/kg/day: 7 male, 7 female
3.Total :104
0 (Vehicle): 13 male and 13 female
100 mg/kg/day: 13 male and 13 female
300 mg/kg/day: 13 male and 13 female
1000 mg/kg/day: 13 male and 13 female
4.Total:80
0 mg/kg bw/day:10 male and 10 female
250mg/kg bw/day:10 male and 10 female
500mg/kg bw/day:10 male and 10 female
1000mg/kg bw/day:10 male and 10 female - Control animals:
- yes, concurrent vehicle
- Details on study design:
- No data available
- Positive control:
- No data available
- Parental animals: Observations and examinations:
- 2.Observations and examinations performed & frequency
CAGE SIDE OBSERVATIONS: Yes
- Time schedule : Twice daily (morning and evening)
- Cage side observations checked in table [No.?] were included. : Viaibility or moribund
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Daily for behavioral changes or reaction to treatment and detailed clinical signs were recorded weekly.
BODY WEIGHT: Yes
- Time schedule for examinations: On day 1, 8, 15, 22, 28, and day 29 (before schedule sacrifice)
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): No data available
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data available
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data available
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No data available
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
- Time schedule for examinations: Weekly once during 28 days of treatment.
3.Parental animals observation and examinations
CAGE SIDE OBSERVATIONS: yes
DETAILED CLINICAL OBSERVATIONS:
Time schedule: Daily
BODY WEIGHT: Yes
Time schedule for examinations: For all males, measurements were made on 1, 8, and 15 days of administration 1 (administration start date), 8, 15,
22, 29, 36, 42 days and postmenopausal days and females for all cases,
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): yes For all males, measurements were made on 1, 8, and 15 days of administration (administration start date), 8, 15,22, 29, 36, 42 days and postmenopausal days and females for all cases,
Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data available
Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data: No data available
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
Time schedule for examinations
4.Parental animals observation and examinations
CAGE SIDE OBSERVATIONS: yes
DETAILED CLINICAL OBSERVATIONS: Yes
Time schedule:
BODY WEIGHT: Yes
Time schedule for examinations:
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): No data available
Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data available
Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data: No data available
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
Time schedule for examinations:
OTHER: - Oestrous cyclicity (parental animals):
- 3.Estrous cycle length and pattern not performed because the test was Conducted by the TG adopted in 1990.
- Sperm parameters (parental animals):
- 3.Sperm examination were not performed because the test was Conducted by the TG adopted in 1990.
- Litter observations:
- 2.Sacrifice and pathology
GROSS PATHOLOGY: Yes
All animals were sacrificed by CO2 asphyxiation. Complete necropsy was carried out on all the animals to score the gross lesions. Tissues were collected from all animals and preserved in 10% formal saline. However, testes, ovaries and uterus were first fixed in Bouin’s fixative for short duration then transferred to 10% formal saline.
HISTOPATHOLOGY: Yes
The required tissues for histology slide preparations were embedded in paraffin wax, five micrometers tissue sections were cut and stained with haematoxylin and eosin and examined for histopathological changes.
Organ examined: Brain, Stomach, Large intestine Small intestine, Liver, Kidneys, Adrenal gland(s), Spleen, Heart, Thymus, Lungs, Testis / Ovary, Uterus, Sciatic nerve Lymph nodes, Peripheral nerve (Sciatic) and Bone marrow were examined.
3.litter size at birth, neonatal death, sex ratio of pups were observed
4.litter size at birth, neonatal death, sex ratio of pups were observed - Postmortem examinations (parental animals):
- 3.Postmortem examinations (Parent Animal)
SACRIFICE : males were killing under pentobarbital sodium deep anesthesia the next day (day corresponding to 43 days of administration). Females delivered were sacrificed on the fourth day of nursing, females that did not deliver to the 25th day of pregnancy, females who did not copulate were exsanguinated and lethal under pentobarbital sodium anesthesia at the end of the mating period,
GROSS NECROPSY: yes
HISTOPATHOLOGY / ORGAN WEIGHTS: yes
Weights of the heart, liver, kidney, thymus, testis and epididymis were measured for all cases ,the testes and epididymis were fixed and stored in Bouin's solution, and other organs and brain, spleen, adrenal gland and bladder were fixed and fixed in 10% formalin. For these high-dose groups and control groups, paraffin sections were prepared according to a conventional method, and hematoxylineosin staining was performed to perform histopathological examination.
4.Postmortem examinations (Parent Animal)
SACRIFICE :Dams were sacrifice on 3 days after lactation
GROSS NECROPSY: yes
HISTOPATHOLOGY / ORGAN WEIGHTS: yes - Postmortem examinations (offspring):
- 3.SACRIFICE
- The F1 offspring not selected as parental animals and all F2 offspring were sacrificed at [#?] days of age.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows:
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations
HISTOPATHOLOGY / ORGAN WEIGTHS
The tissues indicated in Table [#] were prepared for microscopic examination and weighed, respectively.
4.SACRIFICE
- The F1 offspring not selected as parental animals and all F2 offspring were sacrificed at [#?] days of age.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows:
GROSS NECROPSY
- Gross necropsy consisted of [external and internal examinations
HISTOPATHOLOGY / ORGAN WEIGTHS
The tissues indicated in Table [#] were prepared for microscopic examination and weighed, respectively. - Statistics:
- 2.Statistical analysis was carried out by using Microsoft Excel and IBM SPSS statistics version-20.0. All analyses and comparisons were evaluated at the 5 % level, statistically significant differences (p ≤0.05) indicated by appropriate notation. The focus was to examine the mean differences and their significance between control and low dose group, control and mid dose group and control and high dose group. The statistical decision was taken by preparing the univariant GLM MODEL procedure was used to check the significance between above mentioned groups. For multiple comparisons Turkey’s HSD test was applied.
3.Dunnett’s or Scheffe’s test for continuous data, Chi square test for copulated index and fertility index, and Mann-Whitney U test or Fisher’s test for histopathological examination data. - Reproductive indices:
- No data available
- Offspring viability indices:
- No data available
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- 2.effects observed, treatment-related
Soft stool, nasal discharge was observed in all male and female treated animals.
When treated with 250 mg/kg, crust around nostrils in male and perineum soiled with fecal matter in female were observed.
In 1000 mg/kg/dose, red crust around nostrils, perineum soiled and soft feces were observed in female rats.
3.no effects observed
In males, no abnormalities in general conditions were observed. In females, there was only one change from day 42 of administration (day of delivery) to the one in 100 mg / kg administration group (administration 42 days: piloerection, blood-like fluid discharge from the vaginal opening; administration 43 to 44 days: coat contamination) But it recovered on day 45 of administration. In other females, no abnormalities in the general condition were observed
4.no effects observed
There were no treatment-related effects on clinical examination was observed - Dermal irritation (if dermal study):
- not specified
- Mortality:
- no mortality observed
- Description (incidence):
- 2.No mortality was observed in treated animals.
3.no mortality observed
No deaths in male and female was observed. - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- 2.When treated with 500 and 1000 mg/kg/day, In male rat, significant increase were observed. In female rats, significant increase in body weight were observed in 1000 mg/kg/day as compare to control.
3.effects observed, non-treatment-related
In male, the body weight gain increased from 8 to 15 days in the 100 mg / kg administration group significantly (p <0.01) compared with the control group, However, in the group administered with 300 mg / kg or more, there was no significant difference between the control group and treated group. In females, there was no significant difference in body weight and body weight gain between control group and treated group before breeding, pregnancy period and nursing period. - Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- 2.No change was observed in food consumption of male and female rat of treated groups.
3.no effects observed
There was no significant difference between the control group and treated group for males and female at any time of feeding intake - Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Description (incidence and severity):
- 2.No change was observed among all treated male rat but in female rat significant decreased was observed on 4th week of 1000 mg/kg/day dose treatment
- Ophthalmological findings:
- no effects observed
- Description (incidence and severity):
- 2.No abnormalities were observed in all treated dose groups rat.
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- 2.In male rats, when treated with 1000 mg/kg/day testosterone, sodium, total proteins and total cholesterol level were significantly increased and SGOT, SGPT were significantly reduced in treated rats.
Creatinine level was significantly reduced in 500 mg/kg/day treated male rats.
Potassium level was significantly increased in 250 mg/kg/day treated male rat.
When treaed with 1000 mg/kg/day, In female rats, significant reduction were observed in sodium, albumin and glucose level and Total Bile Acids, Potassium and SGPT were significant ly increased as compared to control.
When treated with 500 mg/kg/day, Potassium and SGPT significantly increased and glucose, blood urea nitrogen (BUN) and creatinine were significantly decreased in female treated rat.
When treated with 250 mg/kg/day, Potassium, SGPT and estrogen was significantly increased and SGOT were significantly decreased in female treated rat. - Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, non-treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- 2.Minimal increased were observed in eosinophils of small intestine, collapsed lung, minimal focal fatty change in liver were observed in 1000 mg/kg/day male rats. In female, minimal focal fatty change in liver, minimal reactive spleen and minimal increased in eosinophils of small intestine and mild changes were observed in liver with focal fatty change and reactive spleen was observed in 1000 mg/kg/day dose animals.However, the biological significance of these findings are not related to test chemical.
3.no effects observed
Atrophy of seminiferous tubules was found in 2 animals in the 1000 mg / kg administration group, one on both sides and one on one side, but both were localized and extremely mildly changed. There were no other abnormalities. Sperm granuloma was observed in one of the control group, and there was no abnormality. There were no abnormalities in the ovaries of the unexpanded and infertile cases. - Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- 3.There was no significant difference between the control group and treated group in the mating rate, conception rate, the number of days taken from the start of cohabitation to mating and the number of estrus periods recurred during that period.
An abnormality in labor condition (not treated with placenta) and abnormality in nursing condition (not collecting children, poor protrusion of nipple, poor protrusion of infant, child's fetus) was administered to one of 100 mg / kg administration group, The decrease in body surface temperature) was observed, and all children died on nursing day 2, but no abnormality was observed in other mother animals.
Birth rate was 100% in all administration groups, and no significant difference was observed between gestation period between control group and treated group. No significant difference was observed between the control group and treated group for the number of luteinism, the number of implantation and the implantation rate of pregnant animals.
4.no effects observed
There were no treatment-related changes in mating, fertility and pregnant indices, or in the number of corpora lutea and implantations, pre-implantation loss, post-implantation loss, litter size at birth, neonatal death. - Dose descriptor:
- NOAEL
- Remarks:
- 2.
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- water consumption and compound intake
- ophthalmological examination
- clinical biochemistry
- organ weights and organ / body weight ratios
- gross pathology
- histopathology: non-neoplastic
- Remarks on result:
- other: No toxic effects on reproductive organ was observed
- Dose descriptor:
- NOAEL
- Remarks:
- 3.
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- gross pathology
- histopathology: non-neoplastic
- reproductive performance
- Remarks on result:
- other: overall no toxic effects on reproductive performance
- Dose descriptor:
- NOAEL
- Remarks:
- 4.
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- body weight and weight gain
- food consumption and compound intake
- organ weights and organ / body weight ratios
- gross pathology
- reproductive performance
- Remarks on result:
- other: overall no effects on reproductive performance
- Critical effects observed:
- no
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- 3.There was no significant difference between the control group and treated group for the number of births, delivery rate, birth rate, fertility rate, and survival rate on 4th day of newborn.
4.no mortality observed
There were no treatment-related changes in litter size at birth, neonatal death, viability ratio at the doses tested - Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- 3.There was no significant difference between the control group and the treated group on body weight at 0 and 4 days of nursing
4.no effects observed
There were no treatment-related changes in body weights of pups on day 0 and day 4 of lactation - Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Anogenital distance (AGD):
- not specified
- Nipple retention in male pups:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- 3.No abnormalities were found in all pups examined in either the external observation at day 0 or the autopsy performed at day 4 after birth.
4.no effects observed
There were no treatment-related changes in gross findings at the doses tested. - Histopathological findings:
- not specified
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Dose descriptor:
- NOAEL
- Remarks:
- 3.
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- clinical signs
- mortality
- body weight and weight gain
- gross pathology
- Remarks on result:
- other: overall no developmental toxicity was observed
- Dose descriptor:
- NOAEL
- Remarks:
- 4.
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- mortality
- body weight and weight gain
- gross pathology
- Remarks on result:
- other: No developmental toxic effects observed
- Reproductive effects observed:
- no
- Conclusions:
- The No Observed Adverse Effect level (NOAEL) for the test chemical for reproduction toxicity in test animals were considered to be 1000 mg/Kg bw/day.
- Executive summary:
Data available for the target chemicals was reviewed to determine the toxic nature of the test chemical. The studies are as mentioned below:
In 28 days repeated dose toxicity study, the effect of test chemical was evaluated in male and female Sprague Dawley rats. The test chemical was administered by oral gavage in the concentration of 0, 250, 500 and 1000 mg/kg/ body weight/day. The results showed no effect on mortality, no changes were in food consumption and ophthalmology. Changes were observed in clinical signs like soft stool, nasal discharge, red crust around nostrils, perineum soiled with fecal matter. Significant decreased were observed in water consumption and locomotor activity of female rat in1000 mg/kg dose group. Body weight was increased significantly in male and female rats. Significant changes were observed in the level of testosterone, sodium, total proteins, total cholesterol, SGOT, SGPT, albumin, Blood urea nitrogen (BUN) and Creatinine when treated with 500 and 1000 mg/kg/day. Significant changes were observed in absolute and relative weight of brain, adrenals, spleen, thymus, epididymides, heart, kidneys, ovaries, uterus and liver in 500 and 1000 mg/kg/day. In addition, minimal to mild gross pathological and histopathological changes were observed in liver, spleen and intestine. However, the biological significance of these findings are not related to test chemical. Therefore, NOAEL was considered to be 1000 mg/kg/day when Sprague-Dawley rat exposed to test chemical orally.
In another Combined Repeat Dose and Reproductive / Developmental Toxicity Screening Test of test material were performed on male and female Sprague Dawley rats. The test material was suspended in corn oil in dose concentration0 ,100, 300 and 1,000 mg/kg bw/day and administered via oral gavage route in dose volume 5ml/kg bw. Dose selected on the bases of preliminary test .All the animals were observed for Clinical signs, body weight and food consumption. No deaths in male and female were observed. However, in the group administered with 300 mg / kg or more, there was no significant difference between the control group and treated group. In females, there was no significant difference in body weight and body weight gain between control group and treated group before breeding, pregnancy period and nursing period. There was no significant difference between the control group and treated group for males and female at any time of feeding intake. There was no significant difference between the control group and treated group in the mating rate, conception rate, the number of days taken from the start of cohabitation to mating and the number of estrus periods recurred during that period. An abnormality in labor condition (not treated with placenta) and abnormality in nursing condition (not collecting children, poor protrusion of nipple, poor protrusion of infant, child's fetus) was administered to one of 100 mg / kg administration group,. Atrophy of seminiferous tubules was found in 2 animals in the 1000 mg / kg administration group, one on both sides and one on one side, but both were localized and extremely mildly changed. There were no other abnormalities. Sperm granuloma was observed in one of the control group, and there was no abnormality. There were no abnormalities in the ovaries of the unexpanded and infertile cases. For female In the 100 mg / kg administration group, the actual weight of the kidney decreased significantly (p <0.05) compared to the control group, but not the dose-dependent change. For other organs in male and female, no significant difference was observed between the control group and treated group. Birth rate was 100% in all administration groups, and no significant difference was observed between gestation period between control group and treated group. No significant difference was observed between the control group and treated group for the number of luteinism, the number of implantation and the implantation rate of pregnant animals.There was no significant difference between the control group and treated group for the number of births, delivery rate, birth rate, fertility rate, and survival rate on 4th day of newborn. In addition, no significant difference was observed between the control group and treated group for sex ratio.There was no significant difference between the control group and thetreated grouponbody weight at 0 and 4 days of nursing. Births that showed morphological abnormalities were not observed in the external table observation on thebirthday, necropsy of the dead child, and necropsy on the 4th day of nursing. Hence No Observed Adverse Effect Level (NOAEL) for reproductive and developmental toxicity was considered to be 1000mg/kg bw .When male and femaleSprague Dawley rats were treated with test material orally.
Furthermore,The reproductive and developmental toxicity study of test chemical was performed on male and female Sprague Dawley rats according to OECD TG 421. The test material dissolved in corn oil in dose concentration 0, 250, 500 and 1,000 mg/kg bw/day via oral gavage route. The male rats treated with test material from two weeks prior to mating, during the mating period and, approximately, two weeks post mating (at least 28 days), and to female rats from two weeks prior to mating, during the mating period, gestation period and 3 days after lactation. Ten males and ten females were used in each group. All the animals were observed for clinical signs, mortality and body weight. There were no treatment-related effects on clinical examination, on body weights, necropsy findings or organ weights. There were no treatment-related changes in mating, fertility and pregnant indices, or in the number of corpora lutea and implantations, pre-implantation loss, post-implantation loss, litter size at birth, neonatal death, sex ratio of pups, viability ratio, body weights of pups on day 0 and day 4 of lactation or gross findings at the doses tested. Hence No Observed Adverse Effect Level (NOAEL) for reproductive and developmental toxicity was considered to be 1000mg/kg bw .When male and female Sprague Dawley rats were treated with test chemical orally.
Based on the data available from different studies, NOAEL was considered to be 1000 mg/kg/day for reproductive toxicity, when rodents were treated with test material orally. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Reference
2.
Table: Summary of Body Weights
Treatment group |
Time (Days) |
|||||
1 |
8 |
15 |
22 |
28 |
Terminal day |
|
Males |
||||||
Control |
217.79 |
247.35 |
269.99 |
290.96 |
304.89 |
300.87 |
250 mg/Kg |
224.64 |
254.35 |
279.94 |
305.36 |
318.22 |
313.79 |
500 mg/Kg |
228.39 |
256.96 |
282.73 |
312.63 |
327.08 |
322.00 |
1000 mg/Kg |
233.18* |
261.44* |
284.33* |
312.10* |
322.86 |
319.86 |
Females |
||||||
Control |
194.50 |
206.76 |
217.21 |
231.38 |
234.65 |
231.10 |
250 mg/Kg |
195.28 |
206.89 |
215.12 |
225.92 |
232.35 |
229.71 |
500 mg/Kg |
199.97 |
214.31 |
224.03 |
235.82 |
241.54 |
238.41 |
1000 mg/Kg |
217.27* |
233.49* |
241.12* |
254.07* |
261.27* |
257.44* |
* Significant at p < 0.05 in comparison to control group
Table: Summary of Histopathology findings
Gross findings |
Dose groups |
|||||||
Males |
Females |
|||||||
G1 |
G2 |
G3 |
G4 |
G5 |
G6 |
G7 |
G8 |
|
Incidence (No. of Animals with Findings/ No. of Animals Examined) |
|
|
||||||
|
1/7 |
- |
- |
3/7 |
2/7 |
- |
- |
3/7 |
Lung |
|
|
||||||
Lung Collapsed |
- |
- |
- |
1/7 |
- |
- |
- |
- |
Liver |
|
|
||||||
Focal Fatty change |
- |
- |
- |
3/7 |
1/7 |
- |
- |
1/7 |
Small intestine |
|
|
||||||
Excess Lymphocyetes |
1/7 |
- |
- |
- |
- |
- |
- |
1/7 |
Spleen |
|
|
||||||
Reactive |
- |
- |
- |
- |
1/7 |
- |
- |
1/7 |
3.
Table: Body weight of female rats treated orally with test material in the combined repeat dose and reproductive/ developmental toxicity screening test
Dose (mg/kg) |
0 |
100 |
300 |
1000 |
Days of administration (Pre mating period)
|
|
|
|
|
1 (init. Wt.) |
216.2 ± 6.4 (13) |
216.7 ± 7.0 (13) |
216.6 ± 6.8 (13) |
216.3 ± 6.7 (13) |
8 |
221.4 ± 7.3 (13) |
221.9 ± 8.4 (13) |
219.5 ± 8.4 (13) |
221.4 ± 5.8 (13) |
15 |
233.7 ± 9.6 (13) |
232.0 ± 10.6 (13) |
234.9 ± 10.9 (13) |
231.2 ± 8.8 (13) |
Days of pregnancy |
|
|
|
|
0 |
240.4 ± 8.8 (13) |
238.3 ± 13.1 (12) |
236.7 ± 9.2 (12) |
238.1 ± 10.4 (13) |
7 |
273.8 ± 15.0 (13) |
273.5 ± 12.4 (12) |
270.9 ± 11.3 (12) |
269.3 ± 12.1 (13) |
14 |
312.2 ± 19.7 (13) |
310.4 ± 11.4 (12) |
309.1 ± 14.5 (12) |
301.9 ± 13.4 (13) |
20 |
391.5 ± 24.0 (13) |
383.1 ± 17.3 (12) |
386.2 ± 18.2 (12) |
374.6 ± 16.1 (13) |
Days of lactation |
|
|
|
|
0 |
278.7 ± 16.7 (13) |
270.3 ± 21.0 (12) |
271.8 ± 20.4 (12) |
270.0 ± 24.5 (13) |
4 |
303.2 ± 17.3 (13) |
287.3 ± 15.2 (11) |
297.0 ± 11.1 (12) |
290.7 ± 15.4 (13) |
Values are expressed as mean ± S. D. In grams
Parenthesis indicates number of animals.
Table: Summary of reproductive performance in parental rats treated orally with test material in the combined repeat dose and reproductive/developmental toxicity screening test
Dose (mg/kg) |
0 |
100 |
300 |
1000 |
No. Of mated pairs |
13 |
13 |
13 |
13 |
No. Of copulated pairs |
13 |
12 |
13 |
13 |
Copulation indexa) |
100 |
92.3 |
100 |
100 |
No. Of pregnant animals |
13 |
12 |
12 |
13 |
Fertility indexb) |
100 |
100 |
92.3 |
100 |
Pairing days until copulation (Mean ± S. D.) |
1.5 ± 1.0 |
2.3 ± 1.2 |
2.6 ± 3.8 |
2.5 ± 2.4 |
Frequency of vaginal estrus (Mean ± S. D.) |
1.0 ± 0.0 |
1.0 ± 0.0 |
1.1 ± 0.3 |
1.1 ± 0.3 |
A) Copulation index= (number of copulated pairs/number of mated pairs) X100; %
B) Fertility index= (number of pregnant animals/number of copulated pairs) X100;
Table: Summary of development of pups from Dams treated orally with test material in the combined repeat dose and reproductive/developmental toxicity screening test
Dose (mg/kg) |
0 |
100 |
300 |
1000 |
Number of pregnant females |
13 |
12 |
12 |
13 |
Number of pregnant females with pups alive |
13 |
12 |
12 |
13 |
Gestation indexA) |
100 |
100 |
100 |
100 |
Gestation length in days |
22.2 ± 0.4 (13) |
22.4 ± 0.5 (12) |
22.3 ± 0.5 (12) |
22.2 ± 0.4 (13) |
Number of Corpora lutea |
16.6 ± 1.6 (13) |
16.7 ± 1.8 (12) |
16.8 ± 2.3 (12) |
16.2 ± 1.5 (13) |
Number of implantation sites |
16.1 ± 1.5 (13) |
15.8 ± 2.1 (12) |
16.0 ± 1.5 (12) |
15.2 ± 3.1 (13) |
Implantation indexB) |
96.9 ± 5.1 (13) |
94.8 ± 7.1 (12) |
96.1 ± 6.0 (12) |
93.1 ± 15.2 (13) |
Day 0 of lactation |
|
|
|
|
Number of pups born |
15.2 ± 1.6 (13) |
14.8 ± 2.2 (12) |
15.2 ± 1.5 (12) |
14.3 ± 2.7 (13) |
Delivery indexC) |
94.5 ± 8.0 (13) |
93.5 ± 3.9 (12) |
94.9 ± 4.3 (12) |
94.9 ± 6.2 (13) |
Number of pups alive |
14.9 ± 1.6 (13) |
14.3 ± 2.2 (12) |
15.1 ± 1.6 (12) |
14.1 ± 2.7 (13) |
Birth indexD) |
93.1 ± 8.8 (13) |
90.7 ± 8.7 (12) |
94.3 ± 5.1 (12) |
93.5 ± 7.2 (13) |
Live Birth indexE) |
98.5 ± 2.8 (13) |
97.0 ± 8.5 (12) |
99.4 ± 2.2 |
98.5 ± 4.0 |
Pups in grams |
|
|
|
|
Male |
6.1 ± 0.3 (13) |
6.3 ± 0.4 (12) |
6.2 ± 0.5 (12) |
6.2 ± 0.5 (13) |
Female |
5.9 ± 0.3 (13) |
5.9 ± 0.5 (12) |
5.9 ± 0.4 (12) |
5.9 ± 0.5 (13) |
Sex ratioF) |
1.09 ± 0.46 (13) |
0.94 ± 0.36 (12) |
1.37 ± 0.65 (12) |
1.22 ± 1.18 (13) |
Day 4 of lactation |
|
|
|
|
Number of pups alive |
14.7 ± 1.4 (13) |
13.0 ± 4.7 (12) |
15.1 ± 1.6 (12) |
14.1 ± 2.7 (13) |
Viability indexG) |
98.6 ± 2.7 (13) |
89.4 ± 28.8 (12) |
100.0 ± 0.0 (12) |
100.0 ± 0.0 (13) |
Pup weight in grams |
|
|
|
|
Male |
9.6 ± 0.7 (13) |
9.6 ± 1.5 (11) |
9.9 ± 0.9 (12) |
9.7 ± 1.1 (13) |
Female |
9.4 ± 0.6 (13) |
9.1 ± 1.3 (11) |
9.5 ± 0.8 (12) |
9.4 ± 1.1 (13) |
Values expressed as Mean ± S.D.
Parenthesis indicates the number of litters evaluated
a): gestation index= (Number of pregnant females with pups alive/ Number of pregnant females) X100; %
b): Implantation index= (Number of implantation sites / Number of Corpora lutea) x100; %
c): Delivery index= (Number of pups born/ Number of implantation sites) x100; %
d): Birth index= (Number of pups alive on day 0/ Number of implantation sites) X 100; %
e): Live Birth index (Number of pups alive on day 0/ Number of pups born) X 100; %
f): Sex ratio= (Number of male pups alive on day 0/ Number of female pups alive on day 0)
g): Viability index= (Number of live pups on day 4/ Number of live pups on day 0) X 100; %
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Data is Klimisch 2 and from prediction report.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Reproductive Toxicity :
Data available for the target chemicals was reviewed to determine the toxic nature of the test chemical. The studies are as mentioned below:
In 28 days repeated dose toxicity study, the effect of test chemical was evaluated in male and female Sprague Dawley rats. The test chemical was administered by oral gavage in the concentration of 0, 250, 500 and 1000 mg/kg/ body weight/day. The results showed no effect on mortality, no changes were in food consumption and ophthalmology. Changes were observed in clinical signs like soft stool, nasal discharge, red crust around nostrils, perineum soiled with fecal matter. Significant decreased were observed in water consumption and locomotor activity of female rat in1000 mg/kg dose group. Body weight was increased significantly in male and female rats. Significant changes were observed in the level of testosterone, sodium, total proteins, total cholesterol, SGOT, SGPT, albumin, Blood urea nitrogen (BUN) and Creatinine when treated with 500 and 1000 mg/kg/day. Significant changes were observed in absolute and relative weight of brain, adrenals, spleen, thymus, epididymides, heart, kidneys, ovaries, uterus and liver in 500 and 1000 mg/kg/day. In addition, minimal to mild gross pathological and histopathological changes were observed in liver, spleen and intestine. However, the biological significance of these findings are not related to test chemical. Therefore, NOAEL was considered to be 1000 mg/kg/day when Sprague-Dawley rat exposed to test chemical orally.
In another Combined Repeat Dose and Reproductive / Developmental Toxicity Screening Test of test material were performed on male and female Sprague Dawley rats. The test material was suspended in corn oil in dose concentration0 ,100, 300 and 1,000 mg/kg bw/day and administered via oral gavage route in dose volume 5ml/kg bw. Dose selected on the bases of preliminary test .All the animals were observed for Clinical signs, body weight and food consumption. No deaths in male and female were observed. However, in the group administered with 300 mg / kg or more, there was no significant difference between the control group and treated group. In females, there was no significant difference in body weight and body weight gain between control group and treated group before breeding, pregnancy period and nursing period. There was no significant difference between the control group and treated group for males and female at any time of feeding intake. There was no significant difference between the control group and treated group in the mating rate, conception rate, the number of days taken from the start of cohabitation to mating and the number of estrus periods recurred during that period. An abnormality in labor condition (not treated with placenta) and abnormality in nursing condition (not collecting children, poor protrusion of nipple, poor protrusion of infant, child's fetus) was administered to one of 100 mg / kg administration group,. Atrophy of seminiferous tubules was found in 2 animals in the 1000 mg / kg administration group, one on both sides and one on one side, but both were localized and extremely mildly changed. There were no other abnormalities. Sperm granuloma was observed in one of the control group, and there was no abnormality. There were no abnormalities in the ovaries of the unexpanded and infertile cases. For female In the 100 mg / kg administration group, the actual weight of the kidney decreased significantly (p <0.05) compared to the control group, but not the dose-dependent change. For other organs in male and female, no significant difference was observed between the control group and treated group. Birth rate was 100% in all administration groups, and no significant difference was observed between gestation period between control group and treated group. No significant difference was observed between the control group and treated group for the number of luteinism, the number of implantation and the implantation rate of pregnant animals.There was no significant difference between the control group and treated group for the number of births, delivery rate, birth rate, fertility rate, and survival rate on 4th day of newborn. In addition, no significant difference was observed between the control group and treated group for sex ratio.There was no significant difference between the control group and thetreated grouponbody weight at 0 and 4 days of nursing. Births that showed morphological abnormalities were not observed in the external table observation on thebirthday, necropsy of the dead child, and necropsy on the 4th day of nursing. Hence No Observed Adverse Effect Level (NOAEL) for reproductive and developmental toxicity was considered to be 1000mg/kg bw .When male and femaleSprague Dawley rats were treated with test material orally.
Furthermore,The reproductive and developmental toxicity study of test chemical was performed on male and female Sprague Dawley rats according to OECD TG 421. The test material dissolved in corn oil in dose concentration 0, 250, 500 and 1,000 mg/kg bw/day via oral gavage route. The male rats treated with test material from two weeks prior to mating, during the mating period and, approximately, two weeks post mating (at least 28 days), and to female rats from two weeks prior to mating, during the mating period, gestation period and 3 days after lactation. Ten males and ten females were used in each group. All the animals were observed for clinical signs, mortality and body weight. There were no treatment-related effects on clinical examination, on body weights, necropsy findings or organ weights. There were no treatment-related changes in mating, fertility and pregnant indices, or in the number of corpora lutea and implantations, pre-implantation loss, post-implantation loss, litter size at birth, neonatal death, sex ratio of pups, viability ratio, body weights of pups on day 0 and day 4 of lactation or gross findings at the doses tested. Hence No Observed Adverse Effect Level (NOAEL) for reproductive and developmental toxicity was considered to be 1000mg/kg bw .When male and female Sprague Dawley rats were treated with test chemical orally.
Based on the data available from different studies, NOAEL was considered to be 1000 mg/kg/day for reproductive toxicity, when rodents were treated with test material orally. Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Comparing the NOAEL value and effects observed on rodents, with the criteria of CLP regulation the given test chemical is not likely to classify as reproductive toxicant.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.